Can-Fite Biopharma Ltd SponsoredCan-Fite Biopharma Ltd SponsoredCan-Fite Biopharma Ltd Sponsored

Can-Fite Biopharma Ltd Sponsored

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪15.19 M‬USD
‪−7.63 M‬USD
‪743.00 K‬USD
Beta (1Y)
1.24

About CAN FITE BIO


CEO
Motti Farbstein
Headquarters
Ramat Gan
Founded
1994
FIGI
BBG003CMFDM2
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Analyze a symbol's price movements over past years with our seasonal tools, helping you spot repeating annual trends and better gauge potential market patterns.